Biochemical and Biophysical Research Communications, Vol.391, No.1, 926-930, 2010
SUMOylated IRF-1 shows oncogenic potential by mimicking IRF-2
Interferon regulatory factor-1 (IRF-1) is all interferon-induced transcriptional activator that suppresses tumors by impeding cell proliferation. Recently. we demonstrated that the level of SUMOylated IRF-1 is elevated in tumor cells, and that SUMOylation of IRF-1 attenuates its tumor-suppressive function Here we report that SUMOylated IRF-1 mimics IRF-2, an antagonistic repressor, and shows oncogenic potential. To demonstrate the role of SUMOylated IRF-1 in tumorigenesis, we used SUMO-IRF-1 recombinant protein Stable expression of SUMO-IRF-1 in NIH3T3 cells resulted in focus formation and anchorage-independent growth in soft agar. Inoculation of SUMO-IRF-1-transfected cells into athymic nude mice resulted in tumor formation and infiltration of adipose tissues Finally, we demonstrated that SUMO-IRF-1 transforms NIH3T3 cells in a dose-dependent manner suggesting that SUMOylated IRF-1 may act as an oncogenic protein in tumor cells. (C) 2009 Elsevier Inc. All rights reserved.